Learn more

THERAPEUTIC HUMAN POLYCLONALS

Overview
  • Total Patents
    40
About

THERAPEUTIC HUMAN POLYCLONALS has a total of 40 patent applications. Its first patent ever was published in 2000. It filed its patents most often in China, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are THERAPEUTIC HUMAN POLYCLONALS INC, GTC BIOTHERAPEUTICS INC and BUELOW ROLAND.

Patent filings per year

Chart showing THERAPEUTIC HUMAN POLYCLONALSs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Buelow Roland 24
#2 Platzer Josef 19
#3 Buelow Jens-Ulrich 9
#4 Van Schooten Wim 9
#5 Roland Buelow 5
#6 Schooten Wim-Van 4
#7 Josef Platzer 3
#8 Schooten Wim Van 2
#9 Buelow Ronald 2
#10 Buelow Jeans-Ulrich 1

Latest patents

Publication Filing date Title
CN103710371A Suppression of B-cell apoptosis in transgenic animals expressing humanized immunoglobulin
CN101123981A Improved DNA immunization with recombinase/transposase
WO2005019463A1 Improved transgenesis with humanized immunoglobulin loci
MXPA06000562A Humanized immunoglobulin loci.
CA2634294A1 Production of humanized antibodies in transgenic animals
AU7491800A Immunotherapy with substantially human polyclonal antibody preparations purifiedfrom genetically engineered birds
EP1151010A2 Human polyclonal antibodies from transgenic nonhuman animals
EP1604997A1 Human polyclonal antibodies from transgenic nonhuman animals